Antiphospholipid syndrome: state of the art on clinical practice guidelines
TASK-FORCE REPORT
[SDV]Life Sciences [q-bio]
unmet needs
610
Autoimmunity
European reference network
14TH INTERNATIONAL-CONGRESS
03 medical and health sciences
0302 clinical medicine
616
Medicine and Health Sciences
MANAGEMENT
EVIDENCE-BASED RECOMMENDATIONS
ERN ReCONNET
SYSTEMIC-LUPUS-ERYTHEMATOSUS
ERN ReCONNET; European reference networks; antiphospholipid syndrome; clinical practice guidelines; unmet needs
Unmet Needs
antiphospholipid syndrome, clinical practice guidelines, ERN ReCONNET, European reference networks, unmet needs
HCC MED
Antiphospholipid Syndrome
PREVENTION
3. Good health
European Reference Networks
EULAR RECOMMENDATIONS
THROMBOSIS
PREGNANCY
antiphospholipid syndrome; clinical practice guidelines; ERN ReCONNET; European reference networks; unmet needs; Rheumatology; Immunology and Allergy; Immunology
antiphospholipid syndrome; clinical practice guidelines; ERN ReCONNET; European reference networks; unmet needs
ANTIBODIES
Clinical Practice Guidelines
antiphospholipid syndrome
clinical practice guideline
DOI:
10.1136/rmdopen-2018-000785
Publication Date:
2018-10-18T23:15:34Z
AUTHORS (33)
ABSTRACT
Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial thrombosis, pregnancy complications and the presence of specific autoantibodies called antiphospholipid antibodies. This review aims to identify existing clinical practice guidelines (CPG) as part of the ERN ReCONNET project, aimed at evaluating existing CPGs or recommendations in rare and complex diseases. Seventeen papers providing important data were identified; however, the literature search highlighted the scarceness of reliable clinical data to develop CPGs. With no formal clinical guidelines in place, diagnosis and treatment of APS is largely based on consensus and expert opinion. Patients’ unmet need refers to the understanding of the disease and its clinical picture and implications, the need of education for patients, family members and healthcare providers, as well as to the development of monitoring pathways involving multiple healthcare providers.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (35)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....